Notis-Mcconarty Edward’s Eli Lilly & Co Position
Does Notis-Mcconarty Edward own Eli Lilly & Co (LLY)? Yes — 4.1K shares worth $4M (+1.86% of its 13F portfolio) as of Q1 2026, up from 3.5K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
4.1K
% of Portfolio
+1.86%
Quarters Held
14
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 4.1K | $4M | +1.86% |
| Q4 2025 | 3.5K | $4M | +1.73% |
| Q3 2025 | 2.4K | $2M | +0.86% |
| Q2 2025 | 1.7K | $1M | +0.65% |
| Q1 2025 | 288 | $237,862 | +0.12% |
| Q1 2024 | 349 | $271,508 | +0.11% |
| Q4 2023 | 424 | $247,158 | +0.10% |
| Q3 2023 | 465 | $249,765 | +0.10% |
| Q2 2023 | 475 | $222,765 | +0.08% |
| Q4 2022 | 550 | $201,212 | +0.08% |
| Q3 2022 | 620 | $201,000 | +0.09% |
| Q2 2022 | 670 | $217,000 | +0.09% |
| Q1 2022 | 730 | $209,000 | +0.07% |
| Q4 2021 | 730 | $202,000 | +0.07% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Notis-Mcconarty Edward’s full portfolio or all institutional holders of LLY.